Mycoplasma Hominis Treatment Plan

You have stated that you wish to obtain treatment with Doxycycline Hyclate for a Mycoplasma Hominis infection.

INSTRUCTIONS:

For Mycoplasma Hominis treatment, you must take: One (1) Doxycycline Hyclate 100mg tablet, orally, twice a day (morning and evening), for 7 days.

ALLERGIES:

Do not take Doxycycline if you are pregnant or breastfeeding. This medicine, like all medications, may cause an allergic reaction if you are allergic to similar medicines or components. If you are allergic to any of the following please do not take the medicine and call or message us or see your doctor in person.

  • Tetracyclines (Minocycline, Tetracycline)

CONDITIONS:

We evaluate your health history and the specific health information you provide us; however, if anything changes and you develop or discover that one of these conditions applies to you, please stop taking this medicine and seek care in person:

  • Pregnancy
  • Myasthenia Gravis
  • Oesophagitis (inflammation of your esophagus)

PREGNANCY AND BREASTFEEDING:

Based on available data, Doxycycline is not considered acceptable or safe for use in pregnancy. Examination of current literature indicates there is no likely harm in short term use of Doxycycline with breastfeeding as milk levels are low and absorption by the infant is inhibited by the calcium in breastmilk. As a precautionary measure prolonged (more than 21 days) or repeat courses while breastfeeding should be avoided.

MEDICINES, SUPPLEMENTS, AND FOODS:

We evaluate your health history and the specific health information you provide us; however, if anything changes and you start or discover that you are taking any of the medicines, foods, or supplements listed below, consult with your physician or local care before you take the medicine. Some of these can cause dangerous interactions with the medicine we are prescribing you and we will help you evaluate that risk and decide on an appropriate treatment plan:

  • Dairy (should avoid for 2 hours after treatment)
  • Antacids (should avoid for 2 hours after treatment)
  • Multivitamins (should avoid for 2 hours after treatment)
  • Anticoagulants (Warfarin)
  • Penicillins
  • Barbiturates
  • Antiepileptic medications (Carbamazepine, Phenytoin)
  • Isotretinoin
  • Rifampin

EMERGENCY SIDE EFFECTS:

This medicine can cause dangerous and potentially life-threatening side effects. If any of the emergency side effects listed in the manufacturer’s pamphlet or those below happen to you, please stop taking the medicine and call 911 or seek immediate medical help in person:

  • Sudden onset of chest pain
  • Shortness of breath
  • Difficulty or painful swallowing
  • Severe skin rash and/or itching
  • Facial or throat swelling
  • Blurred vision
  • Severe bloody diarrhea

OTHER SIDE EFFECTS:

This medicine can also cause other side effects. If any of the other side effects listed in the manufacturer’s pamphlet or those below happen to you please stop taking the medicine and see your doctor in person:

  • Sun sensitivity (be sure to wear SPF while taking this medication)
  • Skin hyperpigmentation
  • Abdominal discomfort
  • Diarrhea
  • Vaginal yeast infections
  • Nausea and vomiting

ACCURATE INFORMATION:

We have evaluated your health history and your specific health information you provided and determined it is safe to proceed with oral Doxycycline Hycalate at this time. If your health history changes including diagnoses or medications please consult with a local care provider to ensure it’s safe to proceed.

TREATMENT FAILURE:

This treatment is not 100% effective. It may not work or may only partially resolve the condition for which you are seeking treatment. If it is an emergency, call 911 or seek immediate medical help in person.

MISDIAGNOSIS OR DELAYED DIAGNOSIS:

There is also a risk that we will misdiagnose or fail to diagnose conditions that you may have which could affect our recommendation for treatment. This risk exists with a doctor in person as well but they may have additional signs and symptoms to aid their evaluation. We use an evidence-based practice and guidelines as well as clinical decision support to try to minimize these risks.

ACCEPTING OR DECLINING OUR RECOMMENDATION:

We recommend this treatment because the potential benefits of treatment outweigh the risks. You should evaluate this information as well as the manufacturer’s pamphlet, and any input from your in-person healthcare team, or other information to decide if this treatment plan is appropriate for you. You are free to decline our treatment recommendations although, doing so may prolong symptoms and be associated with negative outcomes.

SHARE WITH YOUR IN-PERSON HEALTHCARE TEAM:

You can access your records anytime. We strongly recommend that you update your in-person doctor, pharmacist, and the rest of your healthcare team to let them know about any new medicines you are taking or other changes in your health.